Page last updated: 2024-12-05

xylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

xylamine: irreversibly inhibits norepinephrine accumulation by rabbit aortic rings in vitro; UD & journal source given agree on structure of cpd; Negwer calls it the bis(2-chloroethyl) cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5706
CHEMBL ID1616379
SCHEMBL ID13137718
MeSH IDM0086157

Synonyms (17)

Synonym
xylamine
n-(2-chloroethyl)-n-ethyl-2-methybenzenemethanamine
benzenemethanamine, n-(2-chloroethyl)-n-ethyl-2-methyl-
n-2-chloroethyl-n-ethyl-2-methylbenzylamine
n-(2-chloroethyl)-n-ethyl-2-methylbenzylamine
2-chloro-n-ethyl-n-[(2-methylphenyl)methyl]ethanamine
78686-02-9
AKOS012693722
DTXSID10229245
CHEMBL1616379
SCHEMBL13137718
2-chloro-n-ethyl-n-(2-methylbenzyl)ethan-1-amine
STARBLD0007116
n-(2-chloroethyl)-n-ethyl-2-methylbenzenemethanamine
benzylamine, n-(2-chloroethyl)-n-ethyl-o-methyl-
923NT4H8G3
(2-chloroethyl)(ethyl)[(2-methylphenyl)methyl]amine

Research Excerpts

Overview

Xylamine is an alkylating agent that is a substrate for and specific irreversible inhibitor of the cocaine-sensitive catecholamine transporter. It functions in catecholine reuptake into neurons and PC12 cells.

ExcerptReferenceRelevance
"Xylamine is an alkylating agent that is a substrate for and specific irreversible inhibitor of the cocaine-sensitive catecholamine transporter that functions in catecholamine reuptake into neurons and PC12 cells. "( Covalent labeling of the cocaine-sensitive catecholamine transporter.
Cho, AK; Howard, BD; Koide, M; Lin, S; Zhang, MB, 1990
)
1.72

Treatment

Xylamine treatment resulted in a loss of approximately 60% of the control level of norepinephrine in the cerebral cortex. Only the weight of dorsal cortex increased with exposure to enriched conditions.

ExcerptReferenceRelevance
"In xylamine-treated rats, only the weight of dorsal cortex increased with exposure to enriched conditions."( Norepinephrine and neural plasticity: the effects of xylamine on experience-induced changes in brain weight, memory, and behavior.
Benloucif, S; Bennett, EL; Rosenzweig, MR, 1995
)
1.05
"Xylamine treatment resulted in a loss of approximately 60% of the control level of norepinephrine in the cerebral cortex."( The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
Dudley, MW, 1988
)
1.21

Dosage Studied

ExcerptRelevanceReference
"3 microM) produced an approximately parallel shift to the right in the dose-response curve to NA."( Inhibitory effect of noradrenaline uptake inhibitors on contractions of rat aortic smooth muscle.
Huang, Y, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (66.67)18.7374
1990's9 (27.27)18.2507
2000's1 (3.03)29.6817
2010's1 (3.03)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.85 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]